Media headlines about Ceres (NASDAQ:CERE) have trended positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Ceres earned a daily sentiment score of 0.27 on Accern’s scale. Accern also assigned news coverage about the biotechnology company an impact score of 46.0882888158549 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
These are some of the media stories that may have effected Accern Sentiment Analysis’s scoring:
- Puerto Rico contractor pays $500K to settle hurricane recovery overtime claim (hrdive.com)
- Body of Ceres man who drowned at New Melones is found (modbee.com)
- A cold and wet August augurs well for Cape fruit (freshplaza.com)
- Ceres FC loses to Aguilas in Copa opener (sunstar.com.ph)
- Baby girl born on Ceres bus (visayandailystar.com)
Shares of CERE stock remained flat at $$0.40 during trading on Wednesday. Ceres has a 1-year low of $0.16 and a 1-year high of $4.80.
Ceres, Inc is an agricultural biotechnology company that develops and markets seeds and traits to produce crops for feed, forages, sugar and other markets. The Company uses a combination of plant breeding, biotechnology and bioinformatics to develop seed products and biotechnology traits. Its Forage sorghum seeds are used for growing feed for livestock, including dairy and beef cattle.
Featured Article: Asset Allocation, Balancing Your Investments
Receive News & Ratings for Ceres Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceres and related companies with MarketBeat.com's FREE daily email newsletter.